Total number of protein in "GO:0061629" GO term: 177
Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADD1-206 | ADD1 | P35611 | Alpha-adducin | chr4 | GO:0061629 | Not Cancer Driver | No | 63 | 0.0854816824966078 | 440 | 39 | 0.0529172320217096 | 0 |
AHR-201 | AHR | P35869 | Aryl hydrocarbon receptor | chr7 | GO:0061629 | Not Cancer Driver | No | 95 | 0.1120283018867924 | 353 | 55 | 0.0648584905660377 | 0 |
ANKRD1-201 | ANKRD1 | Q15327 | Ankyrin repeat domain-containing protein 1 | chr10 | GO:0061629 | Not Cancer Driver | No | 30 | 0.0940438871473354 | 83 | 7 | 0.0219435736677116 | 0 |
ANKRD2-202 | ANKRD2 | Q9GZV1 | Ankyrin repeat domain-containing protein 2 | chr10 | GO:0061629 | Not Cancer Driver | No | 25 | 0.0694444444444444 | 194 | 15 | 0.0416666666666666 | 0 |
AR-201 | AR | P10275 | Androgen receptor | chrX | GO:0061629 | Census, Compendium | Yes | 116 | 0.1260869565217391 | 443 | 38 | 0.0413043478260869 | 144 |
ARNT-202 | ARNT | P27540 | Aryl hydrocarbon receptor nuclear translocator | chr1 | GO:0061629 | Census | Yes | 61 | 0.0773130544993662 | 511 | 47 | 0.0595690747782002 | 0 |
ATF2-201 | ATF2 | P15336 | Cyclic AMP-dependent transcription factor ATF-2 | chr2 | GO:0061629 | Not Cancer Driver | No | 42 | 0.0831683168316831 | 451 | 36 | 0.0712871287128712 | 0 |
ATF4-206 | ATF4 | P18848 | Cyclic AMP-dependent transcription factor ATF-4 | chr22 | GO:0061629 | Not Cancer Driver | No | 46 | 0.131054131054131 | 261 | 33 | 0.094017094017094 | 0 |
BBS1-201 | BBS1 | Q8NFJ9 | Bardet-Biedl syndrome 1 protein | chr11 | GO:0061629 | Not Cancer Driver | No | 52 | 0.087689713322091 | 100 | 9 | 0.0151770657672849 | 11 |
BBS10-201 | BBS10 | Q8TAM1 | Bardet-Biedl syndrome 10 protein | chr12 | GO:0061629 | Not Cancer Driver | No | 46 | 0.0636237897648686 | 67 | 6 | 0.0082987551867219 | 23 |
BBS2-201 | BBS2 | Q9BXC9 | Bardet-Biedl syndrome 2 protein | chr16 | GO:0061629 | Not Cancer Driver | No | 60 | 0.0832177531206657 | 76 | 8 | 0.0110957004160887 | 20 |
BBS4-201 | BBS4 | Q96RK4 | Bardet-Biedl syndrome 4 protein | chr15 | GO:0061629 | Not Cancer Driver | No | 44 | 0.0847784200385356 | 111 | 14 | 0.0269749518304431 | 9 |
BBS5-201 | BBS5 | Q8N3I7 | Bardet-Biedl syndrome 5 protein | chr2 | GO:0061629 | Not Cancer Driver | No | 24 | 0.0703812316715542 | 20 | 0 | 0.0 | 2 |
BBS7-201 | BBS7 | Q8IWZ6 | Bardet-Biedl syndrome 7 protein | chr4 | GO:0061629 | Not Cancer Driver | No | 69 | 0.0965034965034965 | 56 | 4 | 0.0055944055944055 | 4 |
BEX1-201 | BEX1 | Q9HBH7 | Protein BEX1 | chrX | GO:0061629 | Not Cancer Driver | No | 18 | 0.144 | 114 | 17 | 0.136 | 0 |
BHLHE40-201 | BHLHE40 | O14503 | Class E basic helix-loop-helix protein 40 | chr3 | GO:0061629 | Not Cancer Driver | No | 35 | 0.0849514563106796 | 243 | 20 | 0.0485436893203883 | 0 |
BHLHE41-201 | BHLHE41 | Q9C0J9 | Class E basic helix-loop-helix protein 41 | chr12 | GO:0061629 | Not Cancer Driver | No | 11 | 0.0228215767634854 | 213 | 7 | 0.0145228215767634 | 0 |
CD34-201 | CD34 | P28906 | Hematopoietic progenitor cell antigen CD34 | chr1 | GO:0061629 | Not Cancer Driver | No | 48 | 0.1246753246753246 | 221 | 24 | 0.0623376623376623 | 0 |
CEBPA-201 | CEBPA | P49715 | CCAAT/enhancer-binding protein alpha | chr19 | GO:0061629 | Census, Compendium | Yes | 10 | 0.0279329608938547 | 343 | 10 | 0.0279329608938547 | 1 |
CHD4-206 | CHD4 | Q14839 | Chromodomain-helicase-DNA-binding protein 4 | chr12 | GO:0061629 | Census, Compendium | Yes | 312 | 0.1631799163179916 | 978 | 118 | 0.0617154811715481 | 6 |
CITED2-201 | CITED2 | Q99967 | Cbp/p300-interacting transactivator 2 | chr6 | GO:0061629 | Not Cancer Driver | No | 22 | 0.0814814814814814 | 232 | 19 | 0.0703703703703703 | 0 |
CREB1-201 | CREB1 | P16220 | Cyclic AMP-responsive element-binding protein 1 | chr2 | GO:0061629 | Census | Yes | 14 | 0.0428134556574923 | 278 | 13 | 0.0397553516819571 | 0 |
CREBBP-201 | CREBBP | Q92793 | CREB-binding protein | chr16 | GO:0061629 | Census, Compendium | Yes | 217 | 0.0888615888615888 | 1801 | 91 | 0.0372645372645372 | 30 |
CRKL-201 | CRKL | P46109 | Crk-like protein | chr22 | GO:0061629 | Not Cancer Driver | No | 24 | 0.0792079207920792 | 160 | 17 | 0.0561056105610561 | 0 |
CRX-201 | CRX | O43186 | Cone-rod homeobox protein | chr19 | GO:0061629 | Not Cancer Driver | No | 80 | 0.2675585284280936 | 207 | 56 | 0.1872909698996655 | 6 |
CSNK2B-203 | CSNK2B | P67870 | Casein kinase II subunit beta | chr6 | GO:0061629 | Not Cancer Driver | No | 18 | 0.0837209302325581 | 19 | 0 | 0.0 | 3 |
CTBP1-201 | CTBP1 | Q13363 | C-terminal-binding protein 1 | chr4 | GO:0061629 | Not Cancer Driver | No | 30 | 0.0681818181818181 | 123 | 8 | 0.0181818181818181 | 1 |
CTNNB1-201 | CTNNB1 | P35222 | Catenin beta-1 | chr3 | GO:0061629 | Census, Compendium | Yes | 363 | 0.4647887323943662 | 288 | 291 | 0.3725992317541613 | 11 |
DACT1-201 | DACT1 | Q9NYF0 | Dapper homolog 1 | chr14 | GO:0061629 | Not Cancer Driver | No | 131 | 0.1566985645933014 | 604 | 104 | 0.124401913875598 | 1 |
DAXX-202 | DAXX | Q9UER7 | Death domain-associated protein 6 | chr6 | GO:0061629 | Census, Compendium | Yes | 79 | 0.1067567567567567 | 549 | 57 | 0.077027027027027 | 0 |
DDIT3-201 | DDIT3 | P35638 | DNA damage-inducible transcript 3 protein | chr12 | GO:0061629 | Census | Yes | 19 | 0.1124260355029585 | 161 | 17 | 0.1005917159763313 | 0 |
DDRGK1-201 | DDRGK1 | Q96HY6 | DDRGK domain-containing protein 1 | chr20 | GO:0061629 | Not Cancer Driver | No | 26 | 0.0828025477707006 | 181 | 19 | 0.0605095541401273 | 0 |
DHX9-201 | DHX9 | Q08211 | ATP-dependent RNA helicase A | chr1 | GO:0061629 | Compendium | Yes | 125 | 0.0984251968503937 | 332 | 30 | 0.0236220472440944 | 0 |
DMAP1-203 | DMAP1 | Q9NPF5 | DNA methyltransferase 1-associated protein 1 | chr1 | GO:0061629 | Not Cancer Driver | No | 42 | 0.0899357601713062 | 270 | 26 | 0.0556745182012847 | 0 |
DNMT3A-202 | DNMT3A | Q9Y6K1 | DNA (cytosine-5)-methyltransferase 3A | chr2 | GO:0061629 | Census, Compendium | Yes | 143 | 0.156798245614035 | 372 | 44 | 0.0482456140350877 | 14 |
DUSP26-201 | DUSP26 | Q9BV47 | Dual specificity protein phosphatase 26 | chr8 | GO:0061629 | Not Cancer Driver | No | 45 | 0.2132701421800948 | 14 | 4 | 0.0189573459715639 | 0 |
E4F1-201 | E4F1 | Q66K89 | Transcription factor E4F1 | chr16 | GO:0061629 | Not Cancer Driver | No | 61 | 0.0778061224489796 | 464 | 33 | 0.0420918367346938 | 0 |
EGR2-201 | EGR2 | P11161 | E3 SUMO-protein ligase EGR2 | chr10 | GO:0061629 | Compendium | Yes | 58 | 0.1218487394957983 | 352 | 38 | 0.0798319327731092 | 10 |
ELK1-203 | ELK1 | P19419 | ETS domain-containing protein Elk-1 | chrX | GO:0061629 | Not Cancer Driver | No | 39 | 0.0911214953271028 | 329 | 26 | 0.0607476635514018 | 0 |
ENST00000419755 | BBS1 | Q8NFJ9 | Bardet-Biedl syndrome 1 protein | chr11 | GO:0061629 | Not Cancer Driver | No | 52 | 0.0825396825396825 | 132 | 7 | 0.0111111111111111 | 11 |
ENST00000637807 | AHR | P35869 | Aryl hydrocarbon receptor | chr7 | GO:0061629 | Not Cancer Driver | No | 90 | 0.1129234629861982 | 304 | 51 | 0.0639899623588456 | 0 |
EOMES-201 | EOMES | O95936 | Eomesodermin homolog | chr3 | GO:0061629 | Not Cancer Driver | No | 64 | 0.0932944606413994 | 435 | 41 | 0.0597667638483965 | 0 |
EP300-201 | EP300 | Q09472 | Histone acetyltransferase p300 | chr22 | GO:0061629 | Census, Compendium | Yes | 203 | 0.084092792046396 | 1792 | 84 | 0.0347970173985087 | 1 |
EPAS1-201 | EPAS1 | Q99814 | Endothelial PAS domain-containing protein 1 | chr2 | GO:0061629 | Census, Compendium | Yes | 109 | 0.125287356321839 | 451 | 54 | 0.0620689655172413 | 4 |
ESRRB-208 | ESRRB | O95718 | Steroid hormone receptor ERR2 | chr14 | GO:0061629 | Not Cancer Driver | No | 71 | 0.1563876651982378 | 41 | 7 | 0.0154185022026431 | 4 |
ETS1-201 | ETS1 | P14921 | Protein C-ets-1 | chr11 | GO:0061629 | Not Cancer Driver | No | 47 | 0.1065759637188208 | 78 | 6 | 0.0136054421768707 | 0 |
ETS2-202 | ETS2 | P15036 | Protein C-ets-2 | chr21 | GO:0061629 | Not Cancer Driver | No | 55 | 0.1172707889125799 | 128 | 20 | 0.0426439232409381 | 0 |
EXOSC9-201 | EXOSC9 | Q06265 | Exosome complex component RRP45 | chr4 | GO:0061629 | Not Cancer Driver | No | 30 | 0.0683371298405467 | 155 | 11 | 0.0250569476082004 | 1 |
FBP1-201 | FBP1 | P09467 | Fructose-1,6-bisphosphatase 1 | chr9 | GO:0061629 | Not Cancer Driver | No | 24 | 0.0710059171597633 | 19 | 0 | 0.0 | 4 |
FIZ1-201 | FIZ1 | Q96SL8 | Flt3-interacting zinc finger protein 1 | chr19 | GO:0061629 | Not Cancer Driver | No | 39 | 0.0786290322580645 | 199 | 12 | 0.0241935483870967 | 0 |
FOS-201 | FOS | P01100 | Protein c-Fos | chr14 | GO:0061629 | Not Cancer Driver | No | 37 | 0.0973684210526315 | 247 | 28 | 0.0736842105263157 | 0 |
FOXC1-201 | FOXC1 | Q12948 | Forkhead box protein C1 | chr6 | GO:0061629 | Not Cancer Driver | No | 23 | 0.0415913200723327 | 409 | 14 | 0.0253164556962025 | 25 |
GATA1-202 | GATA1 | P15976 | Erythroid transcription factor | chrX | GO:0061629 | Census, Compendium | Yes | 57 | 0.1380145278450363 | 242 | 34 | 0.0823244552058111 | 5 |
GATA2-201 | GATA2 | P23769 | Endothelial transcription factor GATA-2 | chr3 | GO:0061629 | Census, Compendium | Yes | 60 | 0.125 | 372 | 43 | 0.0895833333333333 | 6 |
GATA3-201 | GATA3 | P23771 | Trans-acting T-cell-specific transcription factor GATA-3 | chr10 | GO:0061629 | Census, Compendium | Yes | 99 | 0.2234762979683973 | 368 | 79 | 0.1783295711060948 | 2 |
GATA4-201 | GATA4 | P43694 | Transcription factor GATA-4 | chr8 | GO:0061629 | Not Cancer Driver | No | 34 | 0.0769230769230769 | 297 | 23 | 0.0520361990950226 | 21 |
GBX2-201 | GBX2 | P52951 | Homeobox protein GBX-2 | chr2 | GO:0061629 | Not Cancer Driver | No | 31 | 0.0890804597701149 | 247 | 24 | 0.0689655172413793 | 0 |
GFI1B-202 | GFI1B | Q5VTD9 | Zinc finger protein Gfi-1b | chr9 | GO:0061629 | Not Cancer Driver | No | 45 | 0.1363636363636363 | 142 | 21 | 0.0636363636363636 | 0 |
GSC-201 | GSC | P56915 | Homeobox protein goosecoid | chr14 | GO:0061629 | Not Cancer Driver | No | 13 | 0.0505836575875486 | 109 | 9 | 0.0350194552529182 | 0 |
GSK3B-201 | GSK3B | P49841 | Glycogen synthase kinase-3 beta | chr3 | GO:0061629 | Not Cancer Driver | No | 34 | 0.0809523809523809 | 148 | 6 | 0.0142857142857142 | 0 |
GTF2A1-203 | GTF2A1 | P52655 | Transcription initiation factor IIA subunit 1 | chr14 | GO:0061629 | Not Cancer Driver | No | 37 | 0.0984042553191489 | 260 | 31 | 0.0824468085106382 | 0 |
GTF2A2-202 | GTF2A2 | P52657 | Transcription initiation factor IIA subunit 2 | chr15 | GO:0061629 | Not Cancer Driver | No | 5 | 0.0458715596330275 | 8 | 0 | 0.0 | 0 |
GTF2I-212 | GTF2I | P78347 | General transcription factor II-I | chr7 | GO:0061629 | Compendium | Yes | 122 | 0.1222444889779559 | 365 | 27 | 0.0270541082164328 | 0 |
HAND1-201 | HAND1 | O96004 | Heart- and neural crest derivatives-expressed protein 1 | chr5 | GO:0061629 | Not Cancer Driver | No | 24 | 0.1116279069767441 | 167 | 19 | 0.0883720930232558 | 0 |
HAND2-201 | HAND2 | P61296 | Heart- and neural crest derivatives-expressed protein 2 | chr4 | GO:0061629 | Not Cancer Driver | No | 39 | 0.1797235023041474 | 124 | 24 | 0.1105990783410138 | 0 |
HCLS1-201 | HCLS1 | P14317 | Hematopoietic lineage cell-specific protein | chr3 | GO:0061629 | Not Cancer Driver | No | 81 | 0.1666666666666666 | 448 | 75 | 0.1543209876543209 | 0 |
HDAC1-201 | HDAC1 | Q13547 | Histone deacetylase 1 | chr1 | GO:0061629 | Not Cancer Driver | No | 30 | 0.0622406639004149 | 135 | 5 | 0.0103734439834024 | 0 |
HDAC2-205 | HDAC2 | Q92769 | Histone deacetylase 2 | chr6 | GO:0061629 | Not Cancer Driver | No | 34 | 0.0696721311475409 | 145 | 11 | 0.0225409836065573 | 0 |
HDAC4-201 | HDAC4 | P56524 | Histone deacetylase 4 | chr2 | GO:0061629 | Not Cancer Driver | No | 145 | 0.1337638376383763 | 751 | 95 | 0.0876383763837638 | 3 |
HDAC5-213 | HDAC5 | Q9UQL6 | Histone deacetylase 5 | chr17 | GO:0061629 | Not Cancer Driver | No | 93 | 0.0828877005347593 | 720 | 61 | 0.0543672014260249 | 0 |
HDAC9-212 | HDAC9 | Q9UKV0 | Histone deacetylase 9 | chr7 | GO:0061629 | Not Cancer Driver | No | 222 | 0.2195845697329377 | 631 | 140 | 0.1384767556874381 | 0 |
HES1-201 | HES1 | Q14469 | Transcription factor HES-1 | chr3 | GO:0061629 | Not Cancer Driver | No | 35 | 0.125 | 227 | 30 | 0.1071428571428571 | 0 |
HES6-201 | HES6 | Q96HZ4 | Transcription cofactor HES-6 | chr2 | GO:0061629 | Not Cancer Driver | No | 7 | 0.03125 | 131 | 4 | 0.0178571428571428 | 0 |
HEY1-202 | HEY1 | Q9Y5J3 | Hairy/enhancer-of-split related with YRPW motif protein 1 | chr8 | GO:0061629 | Census | Yes | 26 | 0.0855263157894736 | 172 | 12 | 0.0394736842105263 | 0 |
HEY2-201 | HEY2 | Q9UBP5 | Hairy/enhancer-of-split related with YRPW motif protein 2 | chr6 | GO:0061629 | Not Cancer Driver | No | 50 | 0.1483679525222551 | 181 | 21 | 0.0623145400593471 | 0 |
HIF1A-202 | HIF1A | Q16665 | Hypoxia-inducible factor 1-alpha | chr14 | GO:0061629 | Census | Yes | 54 | 0.0653753026634382 | 436 | 28 | 0.0338983050847457 | 0 |
HIPK2-202 | HIPK2 | Q9H2X6 | Homeodomain-interacting protein kinase 2 | chr7 | GO:0061629 | Not Cancer Driver | No | 124 | 0.1035058430717863 | 686 | 76 | 0.0634390651085141 | 0 |
HIRA-201 | HIRA | P54198 | Protein HIRA | chr22 | GO:0061629 | Not Cancer Driver | No | 104 | 0.1022615535889872 | 289 | 30 | 0.0294985250737463 | 0 |
HMGA2-204 | HMGA2 | P52926 | High mobility group protein HMGI-C | chr12 | GO:0061629 | Census | Yes | 9 | 0.0825688073394495 | 109 | 9 | 0.0825688073394495 | 0 |
HMGB1-203 | HMGB1 | P09429 | High mobility group protein B1 | chr13 | GO:0061629 | Not Cancer Driver | No | 10 | 0.0465116279069767 | 202 | 7 | 0.0325581395348837 | 0 |
HNF4A-201 | HNF4A | P41235 | Hepatocyte nuclear factor 4-alpha | chr20 | GO:0061629 | Not Cancer Driver | No | 113 | 0.2383966244725738 | 127 | 44 | 0.0928270042194092 | 5 |
HSPB1-201 | HSPB1 | P04792 | Heat shock protein beta-1 | chr7 | GO:0061629 | Not Cancer Driver | No | 10 | 0.048780487804878 | 118 | 8 | 0.0390243902439024 | 19 |
ID2-203 | ID2 | Q02363 | DNA-binding protein inhibitor ID-2 | chr2 | GO:0061629 | Not Cancer Driver | No | 13 | 0.0970149253731343 | 52 | 6 | 0.044776119402985 | 0 |
ID4-201 | ID4 | P47928 | DNA-binding protein inhibitor ID-4 | chr6 | GO:0061629 | Not Cancer Driver | No | 5 | 0.031055900621118 | 72 | 1 | 0.0062111801242236 | 0 |
IFI27-205 | IFI27 | P40305 | Interferon alpha-inducible protein 27, mitochondrial | chr14 | GO:0061629 | Not Cancer Driver | No | 7 | 0.0573770491803278 | 0 | 0 | 0.0 | 0 |
ISL1-201 | ISL1 | P61371 | Insulin gene enhancer protein ISL-1 | chr5 | GO:0061629 | Not Cancer Driver | No | 73 | 0.2091690544412607 | 181 | 41 | 0.1174785100286533 | 0 |
JUN-201 | JUN | P05412 | Transcription factor Jun | chr1 | GO:0061629 | Census | Yes | 26 | 0.0785498489425981 | 283 | 17 | 0.0513595166163142 | 0 |
KAT8-201 | KAT8 | Q9H7Z6 | Histone acetyltransferase KAT8 | chr16 | GO:0061629 | Not Cancer Driver | No | 57 | 0.1244541484716157 | 156 | 18 | 0.0393013100436681 | 4 |
KDM1A-201 | KDM1A | O60341 | Lysine-specific histone demethylase 1A | chr1 | GO:0061629 | Not Cancer Driver | No | 48 | 0.056338028169014 | 291 | 21 | 0.0246478873239436 | 3 |
KEAP1-201 | KEAP1 | Q14145 | Kelch-like ECH-associated protein 1 | chr19 | GO:0061629 | Census, Compendium | Yes | 217 | 0.3477564102564102 | 57 | 7 | 0.0112179487179487 | 0 |
KLF4-201 | KLF4 | O43474 | Krueppel-like factor 4 | chr9 | GO:0061629 | Census, Compendium | Yes | 41 | 0.0855949895615866 | 417 | 25 | 0.0521920668058455 | 0 |
LDB1-204 | LDB1 | Q86U70 | LIM domain-binding protein 1 | chr10 | GO:0061629 | Compendium | Yes | 49 | 0.1192214111922141 | 178 | 26 | 0.0632603406326034 | 0 |
LHX3-202 | LHX3 | Q9UBR4 | LIM/homeobox protein Lhx3 | chr9 | GO:0061629 | Not Cancer Driver | No | 28 | 0.070528967254408 | 232 | 10 | 0.0251889168765743 | 2 |
LMO2-202 | LMO2 | P25791 | Rhombotin-2 | chr11 | GO:0061629 | Census | Yes | 24 | 0.1518987341772152 | 14 | 0 | 0.0 | 0 |
MAD2L2-207 | MAD2L2 | Q9UI95 | Mitotic spindle assembly checkpoint protein MAD2B | chr1 | GO:0061629 | Not Cancer Driver | No | 16 | 0.0758293838862559 | 0 | 0 | 0.0 | 1 |
MEF2A-215 | MEF2A | Q02078 | Myocyte-specific enhancer factor 2A | chr15 | GO:0061629 | Not Cancer Driver | No | 32 | 0.0631163708086785 | 450 | 31 | 0.0611439842209073 | 0 |
MEF2C-209 | MEF2C | Q06413 | Myocyte-specific enhancer factor 2C | chr5 | GO:0061629 | Not Cancer Driver | No | 54 | 0.1141649048625792 | 408 | 51 | 0.1078224101479915 | 2 |
MEF2D-201 | MEF2D | Q14814 | Myocyte-specific enhancer factor 2D | chr1 | GO:0061629 | Not Cancer Driver | No | 46 | 0.0882917466410748 | 457 | 43 | 0.0825335892514395 | 0 |
MIXL1-201 | MIXL1 | Q9H2W2 | Homeobox protein MIXL1 | chr1 | GO:0061629 | Not Cancer Driver | No | 18 | 0.0775862068965517 | 157 | 11 | 0.0474137931034482 | 0 |
MKKS-201 | MKKS | Q9NPJ1 | Molecular chaperone MKKS | chr20 | GO:0061629 | Not Cancer Driver | No | 35 | 0.0614035087719298 | 7 | 0 | 0.0 | 22 |
MLX-201 | MLX | Q9UH92 | Max-like protein X | chr17 | GO:0061629 | Not Cancer Driver | No | 35 | 0.1174496644295302 | 176 | 16 | 0.0536912751677852 | 0 |
MLXIPL-201 | MLXIPL | Q9NP71 | Carbohydrate-responsive element-binding protein | chr7 | GO:0061629 | Not Cancer Driver | No | 86 | 0.1009389671361502 | 557 | 54 | 0.0633802816901408 | 0 |
MTA1-201 | MTA1 | Q13330 | Metastasis-associated protein MTA1 | chr14 | GO:0061629 | Not Cancer Driver | No | 68 | 0.0951048951048951 | 328 | 33 | 0.0461538461538461 | 0 |
MTA2-201 | MTA2 | O94776 | Metastasis-associated protein MTA2 | chr11 | GO:0061629 | Not Cancer Driver | No | 59 | 0.0883233532934131 | 283 | 25 | 0.0374251497005988 | 0 |
MTDH-201 | MTDH | Q86UE4 | Protein LYRIC | chr8 | GO:0061629 | Not Cancer Driver | No | 45 | 0.0773195876288659 | 518 | 44 | 0.0756013745704467 | 0 |
MYOCD-201 | MYOCD | Q8IZQ8 | Myocardin | chr17 | GO:0061629 | Not Cancer Driver | No | 228 | 0.2430703624733475 | 856 | 211 | 0.2249466950959488 | 0 |
MYOD1-201 | MYOD1 | P15172 | Myoblast determination protein 1 | chr11 | GO:0061629 | Census | Yes | 35 | 0.109375 | 246 | 26 | 0.08125 | 0 |
NCOR1-201 | NCOR1 | O75376 | Nuclear receptor corepressor 1 | chr17 | GO:0061629 | Census, Compendium | Yes | 265 | 0.1086065573770491 | 2348 | 258 | 0.1057377049180327 | 0 |
NEUROD1-201 | NEUROD1 | Q13562 | Neurogenic differentiation factor 1 | chr2 | GO:0061629 | Not Cancer Driver | No | 68 | 0.1910112359550561 | 203 | 42 | 0.1179775280898876 | 2 |
NFATC1-205 | NFATC1 | O95644 | Nuclear factor of activated T-cells, cytoplasmic 1 | chr18 | GO:0061629 | Not Cancer Driver | No | 127 | 0.1346765641569459 | 727 | 99 | 0.104984093319194 | 0 |
NFE2L2-201 | NFE2L2 | Q16236 | Nuclear factor erythroid 2-related factor 2 | chr2 | GO:0061629 | Census, Compendium | Yes | 235 | 0.3884297520661157 | 402 | 59 | 0.0975206611570247 | 4 |
NHLH2-201 | NHLH2 | Q02577 | Helix-loop-helix protein 2 | chr1 | GO:0061629 | Not Cancer Driver | No | 15 | 0.1111111111111111 | 83 | 7 | 0.0518518518518518 | 0 |
NIF3L1-202 | NIF3L1 | Q9GZT8 | NIF3-like protein 1 | chr2 | GO:0061629 | Not Cancer Driver | No | 38 | 0.1007957559681697 | 43 | 1 | 0.0026525198938992 | 0 |
NKX2-1-203 | NKX2-1 | P43699 | Homeobox protein Nkx-2.1 | chr14 | GO:0061629 | Census, Compendium | Yes | 34 | 0.091644204851752 | 336 | 32 | 0.0862533692722372 | 6 |
NKX2-5-201 | NKX2-5 | P52952 | Homeobox protein Nkx-2.5 | chr5 | GO:0061629 | Not Cancer Driver | No | 43 | 0.132716049382716 | 182 | 19 | 0.0586419753086419 | 52 |
NR0B1-202 | NR0B1 | P51843 | Nuclear receptor subfamily 0 group B member 1 | chrX | GO:0061629 | Not Cancer Driver | No | 74 | 0.1574468085106383 | 97 | 15 | 0.0319148936170212 | 16 |
PARP1-203 | PARP1 | P09874 | Poly [ADP-ribose] polymerase 1 | chr1 | GO:0061629 | Not Cancer Driver | No | 88 | 0.0867850098619329 | 322 | 28 | 0.0276134122287968 | 0 |
PIAS2-204 | PIAS2 | O75928 | E3 SUMO-protein ligase PIAS2 | chr18 | GO:0061629 | Not Cancer Driver | No | 57 | 0.0917874396135265 | 209 | 19 | 0.0305958132045088 | 0 |
PITX1-201 | PITX1 | P78337 | Pituitary homeobox 1 | chr5 | GO:0061629 | Not Cancer Driver | No | 24 | 0.0764331210191082 | 193 | 11 | 0.0350318471337579 | 1 |
PITX2-201 | PITX2 | Q99697 | Pituitary homeobox 2 | chr4 | GO:0061629 | Not Cancer Driver | No | 68 | 0.2145110410094637 | 186 | 41 | 0.1293375394321766 | 12 |
POU1F1-202 | POU1F1 | P28069 | Pituitary-specific positive transcription factor 1 | chr3 | GO:0061629 | Not Cancer Driver | No | 31 | 0.1065292096219931 | 81 | 10 | 0.0343642611683848 | 13 |
POU4F1-201 | POU4F1 | Q01851 | POU domain, class 4, transcription factor 1 | chr13 | GO:0061629 | Not Cancer Driver | No | 33 | 0.0787589498806682 | 274 | 20 | 0.0477326968973747 | 1 |
PPARA-202 | PPARA | Q07869 | Peroxisome proliferator-activated receptor alpha | chr22 | GO:0061629 | Not Cancer Driver | No | 49 | 0.1047008547008547 | 68 | 9 | 0.0192307692307692 | 0 |
PPARGC1A-201 | PPARGC1A | Q9UBK2 | Peroxisome proliferator-activated receptor gamma coactivator 1-alpha | chr4 | GO:0061629 | Not Cancer Driver | No | 91 | 0.1140350877192982 | 613 | 85 | 0.106516290726817 | 0 |
PRDM13-202 | PRDM13 | Q9H4Q3 | PR domain zinc finger protein 13 | chr6 | GO:0061629 | Not Cancer Driver | No | 68 | 0.0961810466760961 | 417 | 37 | 0.0523338048090523 | 0 |
PRKDC-201 | PRKDC | P78527 | DNA-dependent protein kinase catalytic subunit | chr8 | GO:0061629 | Not Cancer Driver | No | 385 | 0.0932655038759689 | 421 | 43 | 0.0104166666666666 | 2 |
PRRX1-201 | PRRX1 | P54821 | Paired mesoderm homeobox protein 1 | chr1 | GO:0061629 | Census, Compendium | Yes | 54 | 0.2204081632653061 | 206 | 37 | 0.1510204081632653 | 1 |
PSMD10-201 | PSMD10 | O75832 | 26S proteasome non-ATPase regulatory subunit 10 | chrX | GO:0061629 | Not Cancer Driver | No | 13 | 0.0575221238938053 | 53 | 4 | 0.0176991150442477 | 0 |
RAD23B-201 | RAD23B | P54727 | UV excision repair protein RAD23 homolog B | chr9 | GO:0061629 | Not Cancer Driver | No | 29 | 0.0709046454767726 | 326 | 24 | 0.0586797066014669 | 0 |
RB1-201 | RB1 | P06400 | Retinoblastoma-associated protein | chr13 | GO:0061629 | Census, Compendium | Yes | 89 | 0.0959051724137931 | 282 | 26 | 0.0280172413793103 | 21 |
RBBP8-201 | RBBP8 | Q99708 | DNA endonuclease RBBP8 | chr18 | GO:0061629 | Not Cancer Driver | No | 72 | 0.0802675585284281 | 751 | 54 | 0.060200668896321 | 1 |
RBPJ-206 | RBPJ | Q06330 | Recombining binding protein suppressor of hairless | chr4 | GO:0061629 | Not Cancer Driver | No | 32 | 0.064 | 151 | 10 | 0.02 | 2 |
RBX1-201 | RBX1 | P62877 | E3 ubiquitin-protein ligase RBX1 | chr22 | GO:0061629 | Not Cancer Driver | No | 9 | 0.0833333333333333 | 18 | 1 | 0.0092592592592592 | 0 |
REST-201 | REST | Q13127 | RE1-silencing transcription factor | chr4 | GO:0061629 | Not Cancer Driver | No | 86 | 0.0783956244302643 | 872 | 68 | 0.0619872379216043 | 4 |
SDR16C5-201 | SDR16C5 | Q8N3Y7 | Epidermal retinol dehydrogenase 2 | chr8 | GO:0061629 | Not Cancer Driver | No | 67 | 0.2168284789644013 | 4 | 0 | 0.0 | 0 |
SETD1A-201 | SETD1A | O15047 | Histone-lysine N-methyltransferase SETD1A | chr16 | GO:0061629 | Not Cancer Driver | No | 111 | 0.0650263620386643 | 1329 | 99 | 0.0579964850615114 | 5 |
SETD3-202 | SETD3 | Q86TU7 | Actin-histidine N-methyltransferase | chr14 | GO:0061629 | Not Cancer Driver | No | 48 | 0.0808080808080808 | 140 | 15 | 0.0252525252525252 | 0 |
SIN3A-202 | SIN3A | Q96ST3 | Paired amphipathic helix protein Sin3a | chr15 | GO:0061629 | Compendium | Yes | 137 | 0.1076197957580518 | 617 | 60 | 0.0471327572663 | 0 |
SMAD2-201 | SMAD2 | Q15796 | Mothers against decapentaplegic homolog 2 | chr18 | GO:0061629 | Census, Compendium | Yes | 58 | 0.1241970021413276 | 137 | 11 | 0.0235546038543897 | 3 |
SMAD3-201 | SMAD3 | P84022 | Mothers against decapentaplegic homolog 3 | chr15 | GO:0061629 | Census, Compendium | Yes | 80 | 0.188235294117647 | 113 | 15 | 0.0352941176470588 | 5 |
SMAD4-201 | SMAD4 | Q13485 | Mothers against decapentaplegic homolog 4 | chr18 | GO:0061629 | Census, Compendium | Yes | 172 | 0.3115942028985507 | 195 | 16 | 0.0289855072463768 | 6 |
SMARCA1-202 | SMARCA1 | P28370 | Probable global transcription activator SNF2L1 | chrX | GO:0061629 | Compendium | Yes | 99 | 0.0939278937381404 | 309 | 28 | 0.0265654648956356 | 0 |
SOX17-201 | SOX17 | Q9H6I2 | Transcription factor SOX-17 | chr8 | GO:0061629 | Compendium | Yes | 64 | 0.1545893719806763 | 379 | 45 | 0.108695652173913 | 2 |
SP1-201 | SP1 | P08047 | Transcription factor Sp1 | chr12 | GO:0061629 | Not Cancer Driver | No | 67 | 0.0853503184713375 | 601 | 53 | 0.0675159235668789 | 0 |
SP3-201 | SP3 | Q02447 | Transcription factor Sp3 | chr2 | GO:0061629 | Not Cancer Driver | No | 50 | 0.0640204865556978 | 588 | 34 | 0.0435339308578745 | 0 |
SPEN-201 | SPEN | Q96T58 | Msx2-interacting protein | chr1 | GO:0061629 | Census, Compendium | Yes | 341 | 0.0930676855895196 | 3072 | 297 | 0.0810589519650655 | 0 |
SPI1-202 | SPI1 | P17947 | Transcription factor PU.1 | chr11 | GO:0061629 | Not Cancer Driver | No | 38 | 0.1407407407407407 | 187 | 28 | 0.1037037037037037 | 2 |
SRF-201 | SRF | P11831 | Serum response factor | chr6 | GO:0061629 | Not Cancer Driver | No | 30 | 0.0590551181102362 | 443 | 29 | 0.0570866141732283 | 0 |
STAT3-201 | STAT3 | P40763 | Signal transducer and activator of transcription 3 | chr17 | GO:0061629 | Census, Compendium | Yes | 93 | 0.1207792207792207 | 152 | 16 | 0.0207792207792207 | 15 |
STING1-201 | STING1 | Q86WV6 | Stimulator of interferon genes protein | chr5 | GO:0061629 | Not Cancer Driver | No | 39 | 0.1029023746701846 | 66 | 12 | 0.0316622691292876 | 4 |
STK4-202 | STK4 | Q13043 | Serine/threonine-protein kinase 4 | chr20 | GO:0061629 | Not Cancer Driver | No | 49 | 0.1006160164271047 | 233 | 20 | 0.0410677618069815 | 0 |
TAF1-204 | TAF1 | P21675 | Transcription initiation factor TFIID subunit 1 | chrX | GO:0061629 | Not Cancer Driver | No | 278 | 0.1484249866524292 | 1174 | 156 | 0.0832888414308595 | 5 |
TAL1-206 | TAL1 | P17542 | T-cell acute lymphocytic leukemia protein 1 | chr1 | GO:0061629 | Census | Yes | 48 | 0.1450151057401812 | 305 | 47 | 0.1419939577039275 | 0 |
TBX20-201 | TBX20 | Q9UMR3 | T-box transcription factor TBX20 | chr7 | GO:0061629 | Not Cancer Driver | No | 95 | 0.2125279642058165 | 201 | 43 | 0.0961968680089485 | 2 |
TBX3-201 | TBX3 | O15119 | T-box transcription factor TBX3 | chr12 | GO:0061629 | Census, Compendium | Yes | 102 | 0.1372812920592193 | 353 | 52 | 0.0699865410497981 | 2 |
TBX5-203 | TBX5 | Q99593 | T-box transcription factor TBX5 | chr12 | GO:0061629 | Not Cancer Driver | No | 125 | 0.2413127413127413 | 351 | 89 | 0.1718146718146718 | 8 |
TBX6-202 | TBX6 | O95947 | T-box transcription factor TBX6 | chr16 | GO:0061629 | Not Cancer Driver | No | 34 | 0.0779816513761468 | 253 | 17 | 0.0389908256880734 | 0 |
TBXT-201 | TBXT | O15178 | T-box transcription factor T | chr6 | GO:0061629 | Not Cancer Driver | No | 85 | 0.1954022988505747 | 255 | 52 | 0.1195402298850574 | 1 |
TCERG1-201 | TCERG1 | O14776 | Transcription elongation regulator 1 | chr5 | GO:0061629 | Not Cancer Driver | No | 68 | 0.0619307832422586 | 811 | 47 | 0.0428051001821493 | 0 |
TCF23-201 | TCF23 | Q7RTU1 | Transcription factor 23 | chr2 | GO:0061629 | Not Cancer Driver | No | 36 | 0.1682242990654205 | 156 | 28 | 0.1308411214953271 | 0 |
TCF3-201 | TCF3 | P15923 | Transcription factor E2-alpha | chr19 | GO:0061629 | Census | Yes | 40 | 0.0611620795107033 | 658 | 40 | 0.0611620795107033 | 0 |
TCF7L2-206 | TCF7L2 | Q9NQB0 | Transcription factor 7-like 2 | chr10 | GO:0061629 | Census, Compendium | Yes | 76 | 0.122778675282714 | 517 | 62 | 0.1001615508885298 | 0 |
TEAD3-201 | TEAD3 | Q99594 | Transcriptional enhancer factor TEF-5 | chr6 | GO:0061629 | Not Cancer Driver | No | 29 | 0.0666666666666666 | 120 | 6 | 0.0137931034482758 | 0 |
TFDP3-201 | TFDP3 | Q5H9I0 | Transcription factor Dp family member 3 | chrX | GO:0061629 | Not Cancer Driver | No | 65 | 0.1604938271604938 | 186 | 33 | 0.0814814814814814 | 0 |
TP53-201 | TP53 | P04637 | Cellular tumor antigen p53 | chr17 | GO:0061629 | Census, Compendium | Yes | 2742 | 6.977099236641221 | 282 | 1364 | 3.470737913486005 | 60 |
TP53BP1-201 | TP53BP1 | Q12888 | TP53-binding protein 1 | chr15 | GO:0061629 | Not Cancer Driver | No | 159 | 0.0806288032454361 | 1638 | 131 | 0.0664300202839756 | 0 |
TP73-208 | TP73 | O15350 | Tumor protein p73 | chr1 | GO:0061629 | Not Cancer Driver | No | 67 | 0.1053459119496855 | 446 | 45 | 0.070754716981132 | 0 |
TRIB1-201 | TRIB1 | Q96RU8 | Tribbles homolog 1 | chr8 | GO:0061629 | Not Cancer Driver | No | 27 | 0.0725806451612903 | 91 | 4 | 0.010752688172043 | 0 |
TRIB2-201 | TRIB2 | Q92519 | Tribbles homolog 2 | chr2 | GO:0061629 | Not Cancer Driver | No | 41 | 0.119533527696793 | 43 | 4 | 0.0116618075801749 | 0 |
TTC8-201 | TTC8 | Q8TAM2 | Tetratricopeptide repeat protein 8 | chr14 | GO:0061629 | Not Cancer Driver | No | 54 | 0.1016949152542373 | 78 | 11 | 0.0207156308851224 | 0 |
UBXN7-201 | UBXN7 | O94888 | UBX domain-containing protein 7 | chr3 | GO:0061629 | Not Cancer Driver | No | 43 | 0.0879345603271983 | 327 | 25 | 0.0511247443762781 | 0 |
UHRF2-201 | UHRF2 | Q96PU4 | E3 ubiquitin-protein ligase UHRF2 | chr9 | GO:0061629 | Not Cancer Driver | No | 67 | 0.0835411471321695 | 254 | 16 | 0.0199501246882793 | 0 |
WWP2-202 | WWP2 | O00308 | NEDD4-like E3 ubiquitin-protein ligase WWP2 | chr16 | GO:0061629 | Not Cancer Driver | No | 87 | 0.1 | 423 | 46 | 0.0528735632183908 | 0 |
XPC-201 | XPC | Q01831 | DNA repair protein complementing XP-C cells | chr3 | GO:0061629 | Census, Compendium | Yes | 64 | 0.0680851063829787 | 484 | 34 | 0.0361702127659574 | 2 |
ZBTB8A-202 | ZBTB8A | Q96BR9 | Zinc finger and BTB domain-containing protein 8A | chr1 | GO:0061629 | Not Cancer Driver | No | 32 | 0.0725623582766439 | 205 | 18 | 0.0408163265306122 | 0 |
ZFPM1-201 | ZFPM1 | Q8IX07 | Zinc finger protein ZFPM1 | chr16 | GO:0061629 | Not Cancer Driver | No | 40 | 0.0397614314115308 | 781 | 21 | 0.0208747514910536 | 0 |
ZFPM2-201 | ZFPM2 | Q8WW38 | Zinc finger protein ZFPM2 | chr8 | GO:0061629 | Not Cancer Driver | No | 310 | 0.2693310165073849 | 660 | 195 | 0.1694178974804517 | 8 |